Navigation Links
Millennium Over-Delivers on 2007 Goals and Financial Guidance
Date:2/7/2008

- Worldwide VELCADE(R) (bortezomib) for Injection sales surpassed $765

million in 2007 -

- VELCADE granted priority review by FDA in newly diagnosed multiple

myeloma, with launch on track for first half of 2008 -

CAMBRIDGE, Mass., Feb. 7 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today reported 2007 non-GAAP net income of $86.9 million and GAAP net income of $14.9 million.(1) These results exceeded the Company's 2007 financial guidance, driven by strong worldwide sales of VELCADE, the global market leader for the treatment of patients with relapsed multiple myeloma.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

"Millennium over-delivered on high expectations in 2007, including the achievement of record financial results," said Deborah Dunsire, M.D., President and Chief Executive Officer. "Millennium is uniquely situated for growth with a blockbuster oncology product, a pipeline of innovative product candidates and strong financials."

"We remain committed to positioning the Company to deliver sustainable earnings growth," stated Marsha Fanucci, Chief Financial Officer. "In 2008, the Company is focused on elevating its success by maximizing the launch of VELCADE in newly diagnosed multiple myeloma, initiating a pivotal trial program with MLN0002 in inflammatory bowel disease and achieving our financial guidance."

2007 Financial Results

-- The Company achieved full-year non-GAAP net income of $86.9 million or

non-GAAP earnings per share of $0.27. The 125 percent increase over

non-GAAP net income in
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
2. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
3. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
4. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
5. Life Sciences Leader Joins Millennium Board of Directors
6. Millennium to Webcast Third-Quarter 2007 Financial and Operational Results
7. Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
8. Millennium Research Group Offers New Marketrack Service that Tracks European Dental Implant Market
9. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
10. Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order
11. Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015   Mapi ... integrating Mapi,s Medical Affairs and global Risk Management ... a previously announced acquisition . ... are conducted by a global team that includes ... have decades of experience in navigating complex safety ...
(Date:3/31/2015)... and NEW YORK , March ... PTBI ), a biopharmaceutical company advancing protein biologic ... that its Korean marketing partner, Hanmi Pharmaceutical Co., ... in Korea from the country,s Ministry of Food ... & Research Institute (KTR) for MuGard, its oncology ...
(Date:3/31/2015)... This June 13th, a distinguished group of ... International Medical Schools will come together in Santa Monica, ... of stem cell therapy in treatments and cures for ... by the Ocular Research Symposia Foundation, Inc. ... meetings of top experts in the field of eye ...
(Date:3/31/2015)... 2015 Diasome Pharmaceuticals, Inc. ( http://www.diasome.com ... that a United States patent has recently been allowed ... , Entitled “Lipid Construct for Delivery of Insulin ... claims related to the use of Diasome’s proprietary Hepatocyte ... insulin to more effectively reach the liver’s metabolic cells, ...
Breaking Biology Technology:Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2
... Hagens, BODY WORLDS 2:,The Original Exhibition of Real ... this Saturday, February 2nd. The acclaimed exhibition,includes the ... a special feature on,the brain., BODY WORLDS ... healthy and unhealthy organs, body section and slices, ...
... Feb. 1 ,Genzyme Corp. (Nasdaq: GENZ ) and ... they have received clearance under the,Hart-Scott-Rodino Antitrust Improvements Act ... Based on this approval, Genzyme will pay,Isis $150 million ... for,$30 per share., Upon completion of final contracts, ...
... Therapeutics (Amex:,CXM) announced that it has completed ... and other accredited or qualified investors,that was ... Asset Management,Company acted as the sole placement ... http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ), The securities were offered ...
Cached Biology Technology:Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2 2Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration 2Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration 3Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration 4Cardium Completes $5.3 Million Registered Direct Offering 2Cardium Completes $5.3 Million Registered Direct Offering 3Cardium Completes $5.3 Million Registered Direct Offering 4
(Date:3/23/2015)... Mass , March 23, 2015 SoundView Technology ... of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView was ... user feedback on their experience with the Wocket in multiple ... at CVS, Whole Foods and other retailers, making both debit ... Kris Tuttle also says, "If the company meets their ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the ...
(Date:3/17/2015)... 2015 MedNet Solutions , a ... study management systems, is pleased to announce that ... Outsourcing in Clinical Trials Southeast conference – March ... excellent forum for MedNet to showcase iMedNet ... (SaaS) eClinical technology platform. We strongly ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... of mythological beliefs. Some cultures prize them for their ... as dagger handles or good luck charms. But new ... by explaining how the horn gets its distinctive curve ... details about the structural materials that form the horn ...
... of Michigan Medical School have discovered a previously unknown ... and renal failure in children: recessive mutations in a ... the mutant gene is important to scientists because PLCE1 ... a vital role in the kidney's ability to remove ...
... found that aged mice undergoing weekly light-cycle shifts--similar to ... shift work--experienced significantly higher death rates than did old ... same eight-week period. The findings may not come as ... the research nonetheless provides, in rather stark terms, new ...
Cached Biology News:Scientists crack rhino horn riddle 2Mutant gene causes severe kidney disease in infants 2Mutant gene causes severe kidney disease in infants 3Mutant gene causes severe kidney disease in infants 4Chronic jet-lag conditions hasten death in aged mice 2
... liquid handling system from Molecular Devices provides ... one instrument. The system handles a variety ... washing96-, 384- and 1536-welland is the first ... has been optimized to dispense from four ...
This free-standing laminar flow hood provides a horizontal flow of HEPA-filtered air to create a clean processing area. Air return slots along the front and side edges of the work area enhance system...
... The B1 series embodies all aspects of ... microscope. With powerful Achromatic Super Contrast (ASC) ... imaging chip, this microscope combines flexibility and ... Motic's popular B1 series, the DM-B1 steps ...
... Sequenase Dye Primer Manual Cycle Sequencing Kit ... dye-labeled primers and high-resolution fluorescence scanners. Sequencing ... standard slab gel electrophoresis and scanning of ... products. The kit components have been ...
Biology Products: